Taikang Life Insurance

Taikang Life Insurance is a Chinese insurance company active as a growth-stage investor in the country's venture capital ecosystem. Its investment activity is executed through Taikang Asset, its asset management arm .

The firm's portfolio spans healthcare technology, enterprise software, and digital supply chain platforms. It led the Series C1 round of StartDT (奇点云), a data technology company, in November 2021 , and participated in the company's later C2 round . In healthcare IT, it led the Series B round of Xiruan Technology (熙软科技), a hospital operations management software provider, in early 2022 . Other disclosed investments include follow-on participation in Xingyun Group's $600 million Series C2 round in 2021 alongside 5Y Capital and Matrix Partners China , and co-investment in community fresh-food chain Qian Damayi (钱大妈)'s nearly RMB 1 billion Series D round in late 2019 .

Taikang Life's investment approach appears oriented toward B2B infrastructure and vertical software, with particular concentration in healthcare and supply chain digitization. The insurer typically participates at the growth stage, often alongside established VC funds such as Gaorong Ventures, Sequoia China, and 5Y Capital .